TECX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
24.2M
-11.3%
27.3M
+26.9%
21.5M
-1.7%
21.9M
-2.0%
22.3M
R&D
18.0M
-13.5%
20.9M
+27.7%
16.3M
-3.5%
16.9M
-1.5%
17.2M
SG&A
6.2M
-4.0%
6.4M
+24.3%
5.2M
+4.3%
5.0M
-3.6%
5.1M
Operating Income
-24218000
+11.3%
-27301000
-26.9%
-21516000
+1.7%
-21890000
+2.0%
-22332000
EBITDA
-23933000
+11.3%
-26997000
-27.4%
-21183000
+1.7%
-21548000
+2.0%
-21992000
Net Income
-22285000
+11.7%
-25241000
-31.3%
-19226000
-1.0%
-19035000
+4.7%
-19984000
EPS (Basic)
$-1.18
+11.9%
$-1.34
-30.1%
$-1.03
-1.0%
$-1.02
+4.7%
$-1.07
EPS (Diluted)
$-1.18
+11.9%
$-1.34
-30.1%
$-1.03
-1.0%
$-1.02
+4.7%
$-1.07
Shares (Diluted)
19.0M
+1.0%
18.8M
+0.2%
18.7M
+0.1%
18.7M
+0.2%
18.7M
Tectonic Therapeutic (TECX) โ€” Financials